Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis

OBJECTIVE: To identify subsets of chronic obstructive pulmonary disease (COPD) patients who are more protected from exacerbations with the use of an inhaled corticosteroid/long-acting β(2) agonist (ICS/LABA) combination, compared with the use of LABA monotherapy. DESIGN: Post hoc cluster analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: DiSantostefano, Rachael L, Li, Hao, Rubin, David B, Stempel, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641457/
https://www.ncbi.nlm.nih.gov/pubmed/23613569
http://dx.doi.org/10.1136/bmjopen-2012-001838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641457/
https://www.ncbi.nlm.nih.gov/pubmed/23613569
http://dx.doi.org/10.1136/bmjopen-2012-001838

Ejemplares similares